alzheimer-disease

Documents about alzheimer-disease

• Stroke-induced gut microbiome dysbiosis accelerates Alzheimer's disease progression.#218977NCBI PubMed Central
• Precision pathways: optimising amyloid PET for sustainable Alzheimer's disease care.#235958NCBI PubMed Central
• Time Distributed Classification of Alzheimer's Disease on MRI Scans#261133AVESIS
• AETA peptide contributes to Alzheimer's disease signature of synapse dysfunction.#262849NCBI PubMed Central
• Mitochondrial dysfunction in Alzheimer's disease: connecting pathophysiology with neuroimaging.#281151NCBI PubMed Central
• Geometric brain signatures of Alzheimer's disease progression and subtypes#282967bioRxiv / medRxiv
• Alzheimer's Disease Pathologies Affect Dopaminergic Neural Mechanisms of Memory.#284861NCBI PubMed Central
• Recursive Support Vector Machine Biomarker Selection for Alzheimer's Disease.#285318NCBI PubMed Central
• The YTHDF proteins shape the brain gene signatures of Alzheimer's disease#290724bioRxiv / medRxiv
• Genomic analyses reveal new insights into Alzheimer's disease#290747bioRxiv / medRxiv
• Greater Amyloid Burden in Cognitive Networks in Preclinical Alzheimer's Disease#310915bioRxiv / medRxiv
• Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.#320384NCBI PubMed Central
• APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease.#320442NCBI PubMed Central
• Association of sleep duration with Alzheimer's disease and cognition.#354869NCBI PubMed Central
• Salivary Cortisol and Cognitive Decline and Alzheimer Disease in Older Adults.#375191NCBI PubMed Central
• Advances in Tricyclic Compounds for the Treatment of Alzheimer's Disease.#380706NCBI PubMed Central
• Performance of Alzheimer Disease Plasma Biomarkers in Patients With Prion Diseases.#388652NCBI PubMed Central
• Cell-type-directed network-correcting combination therapy for Alzheimer's disease.#388810NCBI PubMed Central
• Sex- and brain region-specific gene expression in Alzheimer's disease.#406403NCBI PubMed Central
• Gut immune system in the murine model of Alzheimer’s disease#408602IBISS
• Anti-inflammatory CAR-microglia targeting Aβ for Alzheimer's disease therapy.#412131NCBI PubMed Central
• Metabolomic Discoveries for Traditional Chinese Medicine Efficacy in Alzheimer's Disease.#422825NCBI PubMed Central
• Gut bacterial metabolite imidazole propionate potentiates Alzheimer's disease pathology.#446347NCBI PubMed Central
• Noninvasive Brain Stimulation Techniques and Their Efficacy in Treating Cognition and Memory in Mild Cognitive Impairment and Alzheimer’s Disease—A Systematic Review#231264Europe PMC
• A high-throughput assay for monitoring and quantifying amyloid-β accumulation and clearance in Alzheimer's disease cell models#299040Research Online
• “Las formas de olvido y las formas de memoria: los múltiples sentidos en una dinámica familiar que gira en torno al Alzheimer”,#188251Repositorio Institucional Javeriano
• Preventative semaglutide and tirzepatide treatment does not alter disease progression in the 5xFAD mouse model of Alzheimer's disease.#404260NCBI PubMed Central
• Real-world comparison of brain [<sup>18</sup>F]FDG-PET imaging with CSF Alzheimer's disease biomarkers in a tertiary memory clinic setting#205477Europe PMC
• The intrinsic connectivity between the default mode and dorsal attention networks is an independent fMRI biomarker of Alzheimer's disease pathology burden#370947HAL (France)
• A technical assessment of latent diffusion for Alzheimer's Disease progression.#1353NCBI PubMed Central
• Impacts of host genetics on gut microbiome composition in Alzheimer's disease.#3853NCBI PubMed Central
• Peripheral Insulin Resistance and Alzheimer's Disease: Possible Mediators Including Extracellular Vesicles.#8942NCBI PubMed Central
• Classification of Alzheimer’s Disease Using Traditional Classifiers with Pre-Trained CNN#116236PhilArchive
• Predictive Modeling of Natural Medicinal Compounds for Alzheimer Disease Using Cheminformatics#120538arXiv CS
• Neuronal APOE4-induced early hippocampal network hyperexcitability in Alzheimer's disease pathogenesis.#125320NCBI PubMed Central
• TYK2 mediates neuroinflammation in Alzheimer's disease brains with TDP-43 pathology.#150017NCBI PubMed Central
• Deletion of TNFR1 in astrocytes restores memory in aged Alzheimer's disease mice#151547bioRxiv / medRxiv
• Abnormal amyloid PET usually represents intermediate/high Alzheimer's disease neuropathologic change.#161815NCBI PubMed Central
• Graph-Based Biomarker Discovery and Interpretation for Alzheimer's Disease#183173arXiv (OAI)
• How does type 2 diabetes modify the risk of Alzheimer's disease?#209321NCBI PubMed Central
• Hippocampal subregional texture features associated with Alzheimer’s disease severity and cognition.#209470NCBI PubMed Central
• Robust transcriptomic signatures of Alzheimer's disease progression: validated explainable AI approach.#213872NCBI PubMed Central
• Reduced ULK1 links impaired autophagy and mitophagy to Alzheimer's disease pathology.#218811NCBI PubMed Central
• Region-Specific Brain Atrophy Across Alzheimer’s Disease Stages in the NACC Dataset#225155OSF
• Interpretable deep survival analysis of Alzheimer's disease via metabolic genetic variants.#251014NCBI PubMed Central
• The relationship between personality traits and Alzheimer’s disease: a narrative review.#263149NCBI PubMed Central
• Mechanisms of increased Alzheimer's Disease pathology with R47H and R62H TREM2 variants#264596bioRxiv / medRxiv
• Tanycytic degeneration impairs tau clearance and contributes to Alzheimer’s disease pathology#268584HAL (France)
• A Covalent Protein Painting Assay Differentiates Amyloid-β Polymorphs in Alzheimer Disease.#269425NCBI PubMed Central
• Amyloidosis of bridging veins is a pathologic feature of Alzheimer's disease.#269427NCBI PubMed Central